PRNewsWire
02 Apr 2026, 14:00 UTC · 23w ago
Verdict
Headline takes no side. We score IMMP −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
The TACTI-004 Phase III study for eftilagimod alfa in non-small cell lung cancer has been discontinued for futility.
More negative than 99% of claims this week
Immutep's ADR price plummeted 82.44% to $0.48 following the announcement of the trial's discontinuation.
So whatExtreme price volatility and a massive loss in market capitalization indicate a severe loss of investor confidence in the company's valuation.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 91% of claims this week
Pomerantz LLP is investigating Immutep for potential securities fraud or unlawful business practices related to the trial failure.
More negative than 80% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a securities fraud investigation following the discontinuation of a Phase III clinical trial for futility and a subsequent 82% stock price crash.
More negative than 87% of ticker scores this week
The company is the subject of a class action lawsuit.
More negative than 87% of ticker scores this week
The company is the subject of a class action lawsuit regarding investor losses.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
5h ago
−11.7%
Price agrees with the score
$0.3267 vs $0.3700 close before publication (Apr 1) · not market-adjusted
IMMP chart →
